# Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder

> **NCT03120468** · EARLY_PHASE1 · UNKNOWN · sponsor: **Nassima Ait-Daoud Tiouririne** · enrollment: 16 (estimated)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** Topiramate and N-Acetyl Cysteine
- **DRUG:** Topiramate and Placebo

## Key facts

- **NCT ID:** NCT03120468
- **Lead sponsor:** Nassima Ait-Daoud Tiouririne
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-01
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2020-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03120468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03120468, "Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03120468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*